3 Nasdaq Stocks Investors Love to Hate
The Nasdaq may be approaching another multi-decade high, but don't tell that to short-sellers in these three most hated stocks.
Is Agilent Technologies Due for a Rally?
The tech stock has broken its downtrend, and its moving averages are beginning to slope upward.
Jeff Saut: S&P Suggests Now Is Not the Time to Be Underinvested
Stocks still have room to run, even if there is a short-term pullback on deflation worries in Europe.
Apple Fails to Inspire Investors Today, but the Future Is Bright
Investors are selling the news of Apple's software update, but a longer-term view is necessary.
Todd Harrison: What to Watch as We Slink Into Summer
The NDX holds the key to today's stock market action.
Jason Haver: How Will Equities React to This Long-Term Resistance Zone?
The monthly charts reveal that equities are challenging a long-term trend line.
The VIX Mystery: Here's What Investors Need to Know
With the VIX is near multi-year lows; here's what investors need to know.
Valeant Pharmaceuticals' New Offer for Allergan Falls Short
Valeant Pharmaceuticals improves its offer for Botox maker Allergan, but long-term investors should want more